These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis. Sanders DB; Howard JF; Massey JM Ann N Y Acad Sci; 1993 Jun; 681():588-90. PubMed ID: 8357206 [No Abstract] [Full Text] [Related]
3. 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies. Evoli A; Alboini PE; Damato V; Iorio R Neurology; 2016 Mar; 86(11):1070-1. PubMed ID: 26873957 [No Abstract] [Full Text] [Related]
4. 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS. Oh SJ; Claussen GG; Hatanaka Y; Morgan MB Muscle Nerve; 2009 Nov; 40(5):795-800. PubMed ID: 19722254 [TBL] [Abstract][Full Text] [Related]
5. [Therapy of experimental autoimmune myasthenia gravis in rabbits with 4-aminopyridine and 3,4-diaminopyridine]. Li L; Zhang YP Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):358-62. PubMed ID: 7801782 [TBL] [Abstract][Full Text] [Related]
6. 3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia. Palace J; Wiles CM; Newsom-Davis J J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1069-72. PubMed ID: 1783919 [TBL] [Abstract][Full Text] [Related]
7. Improvement in neuromuscular transmission in myasthenia gravis by 3,4-diaminopyridine. Lundh H; Nilsson O; Rosén I Eur Arch Psychiatry Neurol Sci; 1985; 234(6):374-7. PubMed ID: 2992990 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Howard JF; Barohn RJ; Cutter GR; Freimer M; Juel VC; Mozaffar T; Mellion ML; Benatar MG; Farrugia ME; Wang JJ; Malhotra SS; Kissel JT; Muscle Nerve; 2013 Jul; 48(1):76-84. PubMed ID: 23512355 [TBL] [Abstract][Full Text] [Related]
9. Human type A botulism and treatment with 3,4-diaminopyridine. Davis LE; Johnson JK; Bicknell JM; Levy H; McEvoy KM Electromyogr Clin Neurophysiol; 1992; 32(7-8):379-83. PubMed ID: 1526219 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome. Sanders DB; Massey JM; Sanders LL; Edwards LJ Neurology; 2000 Feb; 54(3):603-7. PubMed ID: 10680790 [TBL] [Abstract][Full Text] [Related]
11. [3,4-diaminopyridine in the treatment of myasthenic syndromes. Practical aspects]. Vílchez JJ; Casanova B; Monte E Med Clin (Barc); 1996 Jan; 106(1):37-8. PubMed ID: 8750543 [No Abstract] [Full Text] [Related]
12. Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. Wirtz PW; Verschuuren JJ; van Dijk JG; de Kam ML; Schoemaker RC; van Hasselt JG; Titulaer MJ; Tjaden UR; den Hartigh J; van Gerven JM Clin Pharmacol Ther; 2009 Jul; 86(1):44-8. PubMed ID: 19357643 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and therapy of congenital myasthenia syndrome]. Sieb JP Dtsch Med Wochenschr; 1999 Jan; 124(1-2):24-9. PubMed ID: 9951456 [No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Meriggioli MN; Rowin J; Richman JG; Leurgans S Ann N Y Acad Sci; 2003 Sep; 998():494-9. PubMed ID: 14592919 [TBL] [Abstract][Full Text] [Related]
15. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis. Polman CH; Bertelsmann FW; de Waal R; van Diemen HA; Uitdehaag BM; van Loenen AC; Koetsier JC Arch Neurol; 1994 Nov; 51(11):1136-9. PubMed ID: 7980110 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine. Lundh H; Nilsson O; Rosén I Neurology; 1984 Oct; 34(10):1324-30. PubMed ID: 6541305 [TBL] [Abstract][Full Text] [Related]
17. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625 [TBL] [Abstract][Full Text] [Related]